We have previously identified and characterised a murine member of the tumour necrosis factor receptor superfamily (TNFRSF), named GITR (TNFR18). 1 ± 4 Most TNFRSF members modulate cell death and induce or counter apoptosis depending on activation of a specific transduction pathway and we showed GITR counters T cell apoptosis. This effect correlates in part with GITR/TRAF-2 binding and consequent NF-kB activation. 5, 6 The GITR cytoplasmic region shows a striking homology with the cytoplasmic region of other TNFRSF members such as CD40 (TNFRSF5), OX40 (TNFRSF4), 4-1BB (TNFRSF9) and CD27 (TNFRSF7) ( Figure 1A ).
2 CD27 stimulation is reported to either protect from, or induce apoptosis, 7 and, in fact, CD27 binding to Siva, a death-domain containing cytoplasmic molecule that is involved in the apoptotic response to virus infection and oxidative stress, 7 ± 9 induces apoptosis activation. On the basis of CD27 and GITR homology at the cytoplasmic domain ( Figure 1A ) we hypothesised that murine GITR (mGITR) could bind murine Siva (mSiva).
To verify whether mGITR and mOX40 bind mSiva, we in vitro translated their cytoplasmic domains together with the mCD27 domain as positive control. The [
35 S]translated products were challenged with the fusion protein GSTmSiva (glutathione S-transferase-GST-fused to mSiva and bound to a sepharose resin) and extensively washed. A GST protein was used as negative control. Figure 1B shows that mGITR, mOX40 and mCD27 bound mSiva. A symmetric experiment using GST-mGITR (cytoplasmic region) and in vitro translated mSiva, confirmed mGITR/ mSiva binding ( Figure 1C ).
To test whether mGITR binds mSiva in vivo, we performed co-immunoprecipitation studies with tagged proteins (mGITR-myc and mSiva-Xpress), overexpressed in Cos7 cells. mSiva-Xpress or mGITR-myc were coimmunoprecipitated with the anti-myc or anti-Xpress antibody (Ab) respectively and revealed by Western blot analysis. Results in Figure 1D indicate that mGITR binds mSiva in vivo. To check any aspecificities due to immunoprecipitating antibodies, lysates from GITR-myc and Siva-Xpress single transfection, immunoprecipitated with anti-Xpress or anti-myc Ab respectively, were used as negative controls. We also evaluated the level of mGITRmyc expression in comparison to that of mGITR in DEXtreated hybridoma T-cells 1 or activated T-lymphocytes 4 by semiquantitative PCR or cytofluorimetric experiments, respectively. Results indicate that similar levels of expression are detected in transfected Cos7 cells and either activated or DEX treated T-cells (data not shown).
To identify the mGITR motif responsible for mSiva binding, we assessed the binding efficacy of 10 in vitro translated mutants of mGITR cytoplasmic domain ( Figure  1E ). The percentage of the product bound to the fusion protein GST-mSiva compared to the input was quantitated upon SDS ± PAGE separation. Figure 1F and G show that mGITR deleted in its C-terminal domain (GITRD30, mutant 1) did not bind mSiva, suggesting the 30 C-terminal amino acidic residues are necessary for mSiva binding. We then investigated the binding ability of several deleted mutants lacking 7 ± 10 amino acidic residues in the C-terminal region ( Figure 1E ) and observed that GITRDc (mutant 4) did not bind mSiva; GITRDa (mutant 2), GITRDb (mutant 3) and GITRDd (mutant 5) bound mSiva less than GITR; and GITRDe (mutant 6) bound mSiva to a similar extent as GITR ( Figure 1F and G). The lack of GITRDc-mSiva binding suggests that the amino acidic residues that are not present in GITRDc (SFQFPEEE) are required for mGITR/mSiva binding. The low binding degree of GITRDa-mSiva suggests that the amino acidic residues that are absent in GITRDa, and N-flanking those missing in GITRDc (QLSAEDAC) play some role. Consequently, we prepared and studied specific mGITR protein mutants ( Figure 1E ) and found that GITR(S180A) (mutant 7), GITR(P190A) (mutant 9) and GITR(E191R,E192V,E193V) (mutant 10) did not bind mSiva, while GITR(E182R,C185G) (mutant 8) bound mSiva to a similar extent as mGITR ( Figure 1F and G) .
The lack of binding of GITRDc, mutant 7, mutant 9 and mutant 10 suggests that the GITR-Siva binding requires specific amino acidic domains. In particular, results indicate that the SFQFPEEE domain (position 186 ± 193) is crucial for mSiva binding, with the PEEE sequence playing an important role. In human GITR (hGITR), the QFPEEE sequence is conserved, suggesting this sequence plays a functional role. Prasad et al 7 and the present results demonstrate that mCD27, hCD27 as well as mOX40 bind Siva. Within these TNFRSF members a PIQE sequence is found in the region corresponding to the PEEE sequence of mGITR and hGITR (see Figure 1A) . Thus, the core motif responsible for Siva binding might be P(I/E)(Q/E)E. The same motif is also present in human 4-1BB and a similar one (PQEE) is found in murine 4-1BB. In human and murine CD40 the PIQE motif is also present, though in different positions of the cytoplasmic domain. Therefore In mGITR, the QLSAEDAC sequence (position 178 ± 185) also plays a role in mSiva binding. Inside the sequence, substitution of E182 and C185 did not modify binding, while S180, a potential Casein Kinase II (CKII) phosphorylation site (SX 2 E/D), 10 was necessary for mSiva binding (see mutant 7 in Figure 1F and G). In hGITR, the consensus for the CKII phosphorylation site is conserved (STED vs SAED of mGITR), providing further evidence that the Ser/Thr phosphorylation site potentially has a functional role. As no conserved CKII phosphorylation sites are found in the cytoplasmic regions of 4-1BB, CD27, CD40 and OX40, this phosphorylation site appears to be peculiar to GITR.
To verify whether the mGITR/mSiva association has a functional role, mGITR and mSiva were co-transfected in Cos7 cells. Results of a representative experiment in Figure  1H show that transfection of either mGITR-myc or mSivaXpress did not induce apoptosis, while co-transfection did. As overexpression of the TNFRSF members is generally accepted to promote low levels of activation, we can assume cotransfection mimics a sort of mGITR triggering. In fact, a potentiated similar effect was obtained by triggering GITR with an anti-mGITR antibody directed against the extracellular region of mGITR ( Figure 1H ). 7 of Cos7 cells co-transfected with mSiva-Xpress and mGITR-myc. Western blot was performed by using anti-myc Ab. On the right panel, the anti-myc Ab against mGITR-myc immunoprecipitates mSiva-Xpress (24 kDa) in lysates of Cos7 cells co-transfected with mSiva-Xpress and mGITR-myc. Western blot was performed by using anti-Xpress Ab. Antibodies were precipitated by using the G-protein, lysates were subjected to a pre-clearing with G-protein and immunoprecipitates were washed five times (three with the lysis buffer and two with PBS). (E) mGITR cytoplasmic domain and its mutants as obtained by in vitro translation. Sixteen amino acids belonging to the GITR transmembrane domain were also in vitro translated (not shown). The three methionine residues at the C-terminal of the translated protein, do not belong to the cytoplasmic domain of GITR but were added to increase specific activity of 35 S-methionine labelled proteins. Numbers indicate the position of the amino acids in the mGITR mature protein and the asterisk indicates the CKII phosphorylation site. Amino acidic residues mutated in the last four mutants are underscored. (F) The 35 S-labelled cytoplasmic domain of mGITR binds GST-Siva fusion protein, while GITRD30 (mutant 1), GITRDc (mutant 4) and GITR(S180A) (mutant 7) do not. For details see Figure 1B . (G) Quantitation (by Instant Imager-Packard) of in vitro binding of mGITR, mCD27, mOX40, and mGITR mutants to mSiva. C.p.m. values of GST bound [
35 S]protein (negative control) were subtracted to that of GST-Siva bound [ 35 S]protein and compared to the c.p.m. of the respective input. GITR mutants are indicated by numbers whose meaning is specified in Figure 1E . (H) Increased apoptosis in cells co-transfected with mGITR-myc and mSiva-Xpress. Cos7 cells were transfected with Fugene (Invitrogen) with the empty vector alone, mSiva-Xpress together with the empty vector, mGITR-myc together with the empty vector, or mGITR-myc together with mSiva-Xpress. Twenty-four hours later, cells were stimulated or not with the anti-GITR antibody and the percentage of apoptotic cells was evaluated by cytofluorimetric analysis of PI stained cells 13 24 h later. One of three similar experiments is shown
